272 Capital’s Silicon Laboratories SLAB Stock Holding History

272 Capital’s Portfolio SLAB Stock Details SLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100	Closed	-$11.6K	–	104
2023 Q3	$11.6K	Buy	+100	New	+$13.8K	﹤0.01%	65

Other funds holding SLAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

272 Capital's SLAB Position: Q4 2023 in Review

272 Capital sold out of Silicon Laboratories (SLAB) in Q4 2023, closing a stake of 100 shares — an estimated $11.6K sold.

272 Capital first reported a position in SLAB in Q3 2023 and held it in 1 quarter. The position peaked at $11.6K in Q3 2023. 295 funds tracked by Wall St. Rank hold SLAB as of Q4 2023.

272 Capital reported no remaining Silicon Laboratories position as of Q4 2023 after selling out during the quarter.
272 Capital sold 100 Silicon Laboratories shares in Q4 2023, an estimated $11.6K.
272 Capital first reported a position in Silicon Laboratories in Q3 2023 and held it in 1 quarter.
272 Capital's Silicon Laboratories position peaked at $11.6K in Q3 2023.
295 funds tracked by Wall St. Rank held Silicon Laboratories as of Q4 2023.

Based on 272 Capital's 13F filing for Q4 2023, filed 15 Feb 2024.